Publications
Applications of Non-Coding RNAs in Multiple Myeloma Patients.
Lymphocyte development and lymphoid disorders, Clinical Applications of Non-Coding RNAs in Cancer Dec 7, 2022
Milestones in acute GVHD pathophysiology.
Immune responses in the immunocompromised host, Front Immunol Dec 5, 2022
Toward practical transparent verifiable and long-term reproducible research using Guix.
Immune responses in the immunocompromised host, Sci Data Oct 4, 2022
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.
Immune responses in the immunocompromised host, Blood Adv. Aug 9, 2022
Context-Dependent Effects Explain Divergent Prognostic Roles of Tregs in Cancer
Human Systems Immunology & Inflammatory Networks, Cancers Jul 17, 2022
Biodistribution of allogenic umbilical cord-derived mesenchymal stromal cells after fetal repair of myelomeningocele in an ovine model
Stem cells biotechnologies, Stem Cell Res Ther. Jul 15, 2022
CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment.
Lymphocyte development and lymphoid disorders, EJHaem Jun 21, 2022
Inflammatory Waldenström’s macroglobulinaemia: A French monocentric retrospective study of 67 patients.
Lymphocyte development and lymphoid disorders, Br J Haematol Jun 19, 2022
The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization
Pathophysiology of breast cancer, Frontiers in Oncology May 25, 2022